LUCENT DIAGNOSTICS
LIVE

Serial Number

98302027

Owner

Quanterix Corporation

Attorney

Christina M. Licursi

First Use Date

Jul 6, 2023

Filing Date

Dec 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LUCENT DIAGNOSTICS Trademark

Serial Number: 98302027

LUCENT DIAGNOSTICS is a trademark filed by Quanterix Corporation on December 6, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Quanterix Corporation (16 trademarks)

Billerica, MA 01821

Entity Type: 03

Trademark Details

Filing Date

December 6, 2023

Registration Date

Not Registered

First Use Anywhere

July 6, 2023

First Use in Commerce

July 6, 2023

Goods & Services

Medical diagnostic reagents and assays for testing bodily fluids; diagnostic testing kits comprised of primarily medical diagnostic reagents and assays and also including specimen containers for testing of bodily fluids for use in disease detection, diagnosing, monitoring, reporting, and treating, namely, neurodegenerative diseases and neurological diseases; clinical diagnostic tests composed of medical diagnostic reagents and assays for testing of body fluids; clinical diagnostic reagents in the nature of medical diagnostic reagents and assay kits composed of medical diagnostic assays for testing body fluids; clinical diagnostic instrumentation and consumables, namely, medical diagnostic reagents and assays for testing of body fluids; clinical diagnostic instrumentation in the nature of clinical medical reagents

diagnostic laboratory services, namely, medical diagnostic services in the nature of analysis, detection and identification of components in bodily samples; medical diagnostic services for determining diseases or disorders, monitoring diseases or disorders, and determining the therapeutic efficacy of treatments for diseases or disorders; clinical diagnostic testing services being medical testing services; clinical diagnostic laboratory and reporting services, namely, medical diagnostic testing, monitoring, and reporting services; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing, monitoring and reporting services; medical testing for disease, illness, and pathology tracking, and treatment purposes

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 2, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 1, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 27, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 25, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 25, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 25, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 6, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2024 NWOS
NEW APPLICATION ENTERED
Dec 6, 2023 NWAP